Werewolf Therapeutics, Inc. (HOWL)

Werewolf Therapeutics Revenue

In the year 2023, Werewolf Therapeutics had annual revenue of $19.94M with 21.60% growth. Revenue in the quarter ending December 31, 2023 was $1.50M, a -79.39% decrease year-over-year.

• Revenue (ttm): $19.94M
• Revenue Growth: +21.60%
• P/S Ratio: 12.85
• Revenue / Employee: $424,319
• Employees: 47
• Market Cap: 258.35M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	19.94M	3.54M	21.60%
Dec 31, 2022	16.40M	-	-
Dec 31, 2021	0	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.